跳至主要内容
临床试验/RPCEC00000040
RPCEC00000040尚未招募1 期

Application of Dermofural ointment in patients with septic burns.

Center for Genetic Engineering and Biotechnology (CIGB)0 个研究点目标入组 20 人开始时间: 2010年12月20日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled trial. Masking: Open. Control group: Uncontrolled. Assignment: Single group. Purpose: Treatment

入排标准

年龄范围
16 years 至 60 years(—)
性别
All

入选标准

  • Cuban patients, of both sexes and any race, with burns type A, AB or B, classified as slight, moderate or serious, requiring occlusion. Presence of sepsis, microbiologically confirmed in lesions, caused by Pseudomonas aeruginosa or any other bacterial agents. Patients aged 16 to 60. Burns by physical agents. Patient’s Informed Consent in writing to participate in the trial and undergo relevant tests.

排除标准

  • Burns by electrical or chemical agents, inhalation, or both. Burns in anal and genital region, and face. Systemic or topical anti-microbial required. Patients who have been on steroid treatment in the last 3 months (any administration route). History of allergy or hypersensitivity to any formulation component. Diabetes mellitus. Immune disease diagnosed. Malignant neoplasia. Chronic kidney failure or liver disorder. Collagen disease. Pregnancy, breastfeeding or puerperium. Severe psychiatric disorder or mental handicap.

研究者

发起方
Center for Genetic Engineering and Biotechnology (CIGB)

相似试验